Article info
ORIGINAL ARTICLE
Topotecan and liposomal doxorubicin in recurrent ovarian cancer: is sequence important?
- Address correspondence and reprint requests to: Jakob Dupont, MD, Developmental Chemotherapy Service, Department of Medicine, Howard 903, Memorial Sloan-Kettering Cancer Center, 1275 York Avenue, New York, NY 10021, USA. Email: dupontj{at}mskcc.org
Citation
Topotecan and liposomal doxorubicin in recurrent ovarian cancer: is sequence important?
Publication history
- First published January 1, 2006.
Online issue publication
January 01, 2006
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
Copyright © 2006 Blackwell Publishing Ltd.